to our drug shortage office, call on the justice department to look at the so-called gray market, which is, again, a real problem when the shortages become apparent that they re being marketed and remarketed much to the abuse of patients, and we have with us today, andrea, a cancer patient from california who is willing to join us, jay kutera, who is himself involved in a drug shortage issue that has been solved but it could happen again. and also a pharmacy manager, bonnie crowley, came from massachusetts. and they really think the actions today around the fda, around the justice department calling on congress will be important pieces of the puzzle that will help make sure patients get the drugs they need. what do you say to businesses, madam secretary, who say the regulatory reviews are cumbersome, that mid-level bureaucrats at fda and deficient heads keep adding and changing